Postgraduate Diploma in Entrepreneurship Biotech and Pharma (Postgraduate Diploma in Entrepreneurship Biotech and Pharma)

Trinity College Dublin (TBC)
Key Programme Details
Award

Postgraduate Diploma

NFQ Level

Level 9 About NFQ

Delivery Method

Blended

Mode

Full Time

ECTS Credits

60

Department

Physiology

General Information
Contact

Professor Kumlesh Dev

Email

devk@tcd.ie

Phone

TBC

Address

TBC

Role

TBC

Important Dates
Application Deadline

30/11/2020

Start Date

20/01/2021

End Date

15/12/2021

About this Course

A new Postgraduate Diploma in “Entrepreneurship Biotech & Pharma”, will be offered to entrepreneurs, business and healthcare professionals.

There will be six taught modules in this course, each of 10 ECTS, totalling 60ECTS:
(1) Cell Biology for the Entrepreneur
(2) Major Disease Markets
(3) How to Make a Drug
(4) Clinical Development & Regulatory Bodies
(5) Valuation of Drugs Products
(6) Setting up a Biotech.

Student on full time one year course will complete all 6 modules in one year. Student on part time two-year course will complete modules 1-3 in year one and modules 4-6 in year two.

Overall, this course is designed to provide a new skills and knowledge to those coming from a non-biology background in the art form of drug discovery and pharmaceutical development. The course is also designed to provide new skills and knowledge in pharmaceutical commercialisation to those who are knowledgeable in the area of biology.

This course will build in a certain level of flexibility. The general module structure is provided below.
• Introductory Online Sessions (Totaling 5 hours) – Each module will start with 5 x 1h Online Tutorials (conducted via zoom or Microsoft teams). These will be conducted over a 2-week period on Mon, Wed, Fri, Mon and Wed.
• Onsite Face-to-Face Teaching Block (Totaling 40 hours) – After the introductory online session, students will attend onsite face-to-face teaching. These will be conducted over a 1-week period from Mon-Fri/Sat i.e. 8 hours per day for 5 days. Each day will be composed of lectures, group discussions, short tasks and group presentations. These 1-week teaching blocks will be interactive and discursive – a flipped classroom model. In general, there will be 2-3 topics per day. Each topic will be composed of:
(1) an introductory lecture
(2) organization of students into groups of 3-4 people
(3) an assigned task/question on the topic for the student groups to discuss
(4) creation of a short a few minutes long individual presentation
(5) presentations by the student groups
(6) a summarizing lecture to close out the topic

• Revision Online Sessions (Totaling 5 hours) – After the onsite face-to-face teaching, a set of online tutorials will be provided. Each module will have 5 x 1h revision online tutorials (conducted via zoom or Microsoft teams). These will be conducted over a 2-week period on Mon, Wed, Fri, Mon and Wed.

• Note: small changes to the hours/days/timetable/structure may change

Objectives

On successful completion of the course students should be able to achieve the course learning outcomes (CLOs):
CLO1 Describe how cells communicate and how cell communication is lost in disease and apply this knowledge to propose new drug targets.
CLO2 Describe how drugs on the market work to regulate drug targets and cell function and apply this knowledge to develop novel intellectual property.
CLO3 Explain classical and novel methods of drug development and develop drug development processes for novel therapies.
CLO4 Utilise classical and alternative routes of the clinical development process, and demonstrate capacity to select appropriate routes of regulatory pathways.
CLO5 Financially value intellectual property and value the current and future value of products and companies for licensing.
CLO6 Develop an ability to establish a limited company, deliver business plans, investor pitches and engagement, and explain how to seek financial backing.

Entry Requirements

Admission to the course is competitive. Applicants will be expected to have an Honors Bachelor degree at 2.1 or above.

Applicants should have a primary degree in science (e.g. cell biology, immunology, neuroscience, pharmacology, physiology), health sciences (e.g. medicine, nursing, allied health) and/or business (e.g. entrepreneurs, business specialists, venture consultants). Applicants with other primary degrees will be considered.

Applicants should have an interest in drug development and commercialisation.

Preferred entry requirements will be a degree in business or biology.

This course is for:
- biologists who would have a deep interest in and would like to gain expertise in drug development and business
- those in business who would like to use their commercial background to enter into drug development/biotech

We will provide the basics in both, and then move into the commercial and drug development modules.

Long Description

The proposed new course has been designed to a new Postgraduate conversion Diploma in “Entrepreneurship Biotech & Pharma”, which will be offered to entrepreneurs, business and healthcare professionals.

There will be six taught modules in this course:
(1) Cell Biology for the Entrepreneur
(2) Major Disease Markets
(3) How to Make a Drug
(4) Clinical Development & Regulatory Bodies
(5) Valuation of Drug Products
(6) Setting up a Biotech

Student on full time one year course will complete all 6 modules in one year. Student on part time two-year course will complete modules 1-3 in year one and modules 4-6 in year two.

Overall, this course is designed to provide a new skills and knowledge to those coming from a non-biology background in the art form of drug discovery and pharmaceutical development. The course is also designed to provide new skills and knowledge in pharmaceutical commercialisation to those who are knowledgeable in the area of biology

The course will follow the lifespan of therapeutic development, from initial birth of a drug development idea to death by competitive market. Modules M1 (Cell Biology for the Entrepreneur), M2 (Major Disease Markets), M3 (How to Make a Drug) and M4 (Clinical Development & Regulatory Bodies) will describe how cell biology, drug development and clinical development is conducted to create novel therapies, where companies invest significant financial resources. The market phase will be discussed in the Modules M5 (Valuation of Drug Products) and M6 (Setting up a Biotech). The course will discuss and provide training in major topics including: Early Product/Technology Development, Clinical Development, Regulatory/Approval, Manufacturing, Financing, Intellectual Property & Licensing, Market Overview, Competitive Landscape, Product Pricing & Sales Forecasting, Risk Analysis, Valuation of Products and Companies and much more.

This course will build a future legacy in drug development and healthcare education.

Timetable Info

TBC

Delivery Location

This course will build in a certain level of flexibility. The general module structure is provided below.
• Introductory Online Sessions (Totaling 5 hours) – Each module will start with 5 x 1h Online Tutorials (conducted via zoom or Microsoft teams). These will be conducted over a 2-week period on Mon, Wed, Fri, Mon and Wed.

• Onsite Face-to-Face Teaching Block (Totaling 40 hours) – After the introductory online session, students will attend onsite face-to-face teaching. These will be conducted over a 1-week period from Mon-Fri/Sat i.e. 8 hours per day for 5 days. Each day will be composed of lectures, group discussions, short tasks and group presentations. These 1-week teaching blocks will be interactive and discursive – a flipped classroom model. In general, there will be 2-3 topics per day. Each topic will be composed of:
(1) an introductory lecture
(2) organization of students into groups of 3-4 people
(3) an assigned task/question on the topic for the student groups to discuss
(4) creation of a short a few minutes long individual presentation
(5) presentations by the student groups
(6) a summarizing lecture to close out the topic

• Revision Online Sessions (Totaling 5 hours) – After the onsite face-to-face teaching, a set of online tutorials will be provided. Each module will have 5 x 1h revision online tutorials (conducted via zoom or Microsoft teams). These will be conducted over a 2-week period on Mon, Wed, Fri, Mon and Wed.

• Note: small changes to the hours/days/timetable/structure may change

Delivery Notes

Blended delivery

Admissions Contact Details
Contact Person

TBC

Address

TBC

Phone

TBC

Application Procedures

All applicants will be interviewed before acceptance onto the course.